Clinical Trials Directory

Trials / Completed

CompletedNCT00280501

Dopaminergic Modulation of Choroidal Blood Flow Changes During Dark/Light Transitions

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
21 (actual)
Sponsor
Medical University of Vienna · Academic / Other
Sex
Male
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

There is evidence from a variety of animal studies that choroidal blood flow is under neural control. By contrast, only little information is available from human studies. Recent results indicate that a light/dark transition is associated with a reduction in choroidal blood flow due to an unknown mechanism. We have shown that during unilateral dark/light transitions both eyes react with choroidal vasoconstriction strongly indicating a neural mechanism responsible for the blood flow changes. Dopamine has been discussed as a chemical messenger for light adaptation. However, dopaminergic effects in the eye are not restricted to synaptic sites of release, but dopamine also diffuses to the outer retinal layers and pigment epithelium. Accordingly, dopaminergic effects also include a modulatory role on retinal vessel diameter and animal studies provide evidence for vasodilatory effects in the choroid. There is evidence that during darkness retinal and choroidal dopamine levels decrease. Accordingly, dopamine could provide a modulatory input to the light/dark transition induced changes of choroidal circulation. The aim of the present study is to test this hypothesis.

Conditions

Interventions

TypeNameDescription
DRUGQuetiapine (drug)Quetiapine (Seroquel 100mg-film-coated tablet, AstraZeneca Vienna, Austria) Dose: 100 mg tablet oral single dose
DRUGSulpiride (drug)Sulpiride (Dogmatil 200mg-tablet, Synthélabo Groupe, Le Plessis Robinson, France) Dose: one half of 200 mg tablet oral single dose
DRUGPlaceboPlacebo

Timeline

Start date
2005-08-01
Primary completion
2006-08-01
Completion
2006-08-01
First posted
2006-01-23
Last updated
2008-07-09

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT00280501. Inclusion in this directory is not an endorsement.